Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder

NCT00795925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: propiverine hydrochloride

Sponsor

APOGEPHA Arzneimittel GmbH